Yiwei Li Selected Research

Isoflavones

10/2013	Perspectives on the role of isoflavones in prostate cancer.
9/2013	Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment.
7/2013	Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?
1/2013	Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.
8/2012	Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion.
1/2012	Targeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasis.
1/2012	Targeting the Hedgehog signaling pathway for cancer therapy.
10/2011	Induction of cancer cell death by isoflavone: the role of multiple signaling pathways.
6/2010	Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.
6/2010	Implication of microRNAs in drug resistance for designing novel cancer therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiwei Li Research Topics

Disease

106	Neoplasms (Cancer) 05/2022 - 01/2002
40	Prostatic Neoplasms (Prostate Cancer) 06/2021 - 01/2002
28	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 05/2004
28	Neoplasm Metastasis (Metastasis) 03/2021 - 01/2002
16	Carcinogenesis 08/2021 - 01/2002
12	Inflammation (Inflammations) 01/2022 - 01/2008
9	Breast Neoplasms (Breast Cancer) 12/2012 - 01/2003
5	Body Weight (Weight, Body) 01/2022 - 01/2020
5	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2020
5	Hypoxia (Hypoxemia) 03/2021 - 01/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2018
4	Insulin Resistance 02/2020 - 04/2011
3	Dysbiosis 01/2022 - 02/2020
3	Cachexia 12/2021 - 01/2021
3	Atrophy 12/2021 - 01/2021
3	Heart Failure 12/2020 - 01/2018
3	Shock 08/2018 - 07/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 10/2013
2	Thrombocytopenia (Thrombopenia) 03/2022 - 09/2020
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2020
2	Muscular Atrophy (Muscle Atrophy) 06/2021 - 01/2021
2	COVID-19 09/2020 - 08/2020
2	Infections 08/2020 - 01/2020
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2019 - 12/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 11/2018
2	Myocardial Infarction 01/2019 - 01/2018
2	Acute Lung Injury 08/2018 - 06/2009
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2012 - 06/2009

Drug/Important Bio-Agent (IBA)

37	MicroRNAs (MicroRNA)IBA 02/2022 - 04/2008
31	NF-kappa B (NF-kB)IBA 07/2013 - 07/2002
27	IsoflavonesIBA 10/2013 - 01/2002
24	GenisteinIBA 01/2014 - 01/2002
22	Biological ProductsIBA 12/2020 - 01/2003
17	3,3'-diindolylmethane (diindolylmethane)IBA 01/2016 - 04/2003
14	Proteins (Proteins, Gene)FDA Link 05/2022 - 06/2002
13	CurcuminIBA 01/2013 - 11/2004
10	Transcription Factors (Transcription Factor)IBA 08/2018 - 04/2003
10	AndrogensIBA 01/2018 - 01/2002
10	Androgen Receptors (Androgen Receptor)IBA 01/2016 - 10/2006
9	Pharmaceutical PreparationsIBA 01/2021 - 06/2010
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 12/2002
9	Hormones (Hormone)IBA 10/2011 - 03/2004
9	indole-3-carbinolIBA 06/2010 - 01/2003
7	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 01/2005
7	AntioxidantsIBA 01/2015 - 01/2002
7	Docetaxel (Taxotere)FDA Link 05/2006 - 03/2004
6	Therapeutic UsesIBA 01/2021 - 03/2004
6	Phosphotransferases (Kinase)IBA 07/2014 - 07/2002
6	Complementary DNA (cDNA)IBA 07/2010 - 12/2002
6	Matrix Metalloproteinases (MMPs)IBA 12/2007 - 12/2002
5	LipopolysaccharidesIBA 01/2020 - 07/2004
5	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 01/2006
5	Gemcitabine FDA Link 03/2012 - 09/2003
4	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2003
4	Estrogens (Estrogen)FDA Link 01/2020 - 01/2002
4	Small Interfering RNA (siRNA)IBA 02/2015 - 03/2006
4	Epithelial Cell Adhesion MoleculeIBA 08/2014 - 08/2011
4	Cisplatin (Platino)FDA LinkGeneric 04/2006 - 05/2004
3	selinexorIBA 05/2022 - 10/2017
3	Linseed Oil (Flaxseed Oil)IBA 01/2022 - 01/2020
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 01/2020
3	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2022 - 01/2020
3	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 12/2021
3	LipidsIBA 01/2022 - 01/2014
3	p21-Activated KinasesIBA 12/2021 - 01/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021 - 06/2007
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2012
3	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 04/2011
3	Insulin (Novolin)FDA Link 02/2020 - 04/2011
3	HMGB1 Protein (HMG1)IBA 08/2018 - 06/2016
3	ErbB Receptors (EGF Receptor)IBA 10/2013 - 08/2006
3	Platelet-Derived Growth FactorIBA 08/2010 - 12/2007
3	Jagged-1 ProteinIBA 03/2010 - 11/2006
3	LigandsIBA 03/2010 - 11/2006
3	thiazolyl blueIBA 09/2007 - 03/2006
3	matrigelIBA 04/2007 - 03/2006
3	Epidermal Growth Factor (EGF)IBA 01/2005 - 07/2002
2	Inulin FDA Link 01/2022 - 01/2020
2	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2021
2	Niacinamide (Nicotinamide)FDA LinkGeneric 12/2021 - 10/2021
2	NAD (NADH)IBA 12/2021 - 10/2021
2	TransferasesIBA 12/2021 - 10/2021
2	KPT-9274IBA 12/2021 - 10/2021
2	16S Ribosomal RNAIBA 12/2021 - 01/2020
2	EnzymesIBA 12/2021 - 10/2021
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 10/2021 - 01/2019
2	Exportin 1 ProteinIBA 06/2021 - 10/2017
2	Troponin IIBA 01/2021 - 01/2018
2	CholesterolIBA 01/2021 - 01/2020
2	Indicators and Reagents (Reagents)IBA 05/2020 - 01/2003
2	Testosterone (Sustanon)FDA Link 01/2020 - 01/2018
2	indoleIBA 09/2013 - 08/2010
2	garcinolIBA 12/2012 - 10/2012

Therapy/Procedure

54	Therapeutics 05/2022 - 12/2004
9	Chemoprevention 07/2013 - 01/2002
7	Drug Therapy (Chemotherapy) 10/2021 - 04/2006
5	Radiotherapy 05/2014 - 04/2006
4	Catheters 01/2019 - 01/2018
3	Oral Administration 05/2022 - 03/2012
3	Castration 06/2021 - 02/2015